Stephen W. Booth
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Oncology top 5%
- COVID-19 and healthcare impacts
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 15
- COVID-19 and healthcare impacts 9
- Viral-associated cancers and disorders 3
-
- Lymphoma Diagnosis and Treatment 11
- Co-authors
- Bruno Fattizzo (2 shared papers)John Charles Riches (2 shared papers)Lydia Scarfò (2 shared papers)Thomas Chatzikonstantinou (2 shared papers)Lisa K. Hicks (2 shared papers)Abi Vijenthira (2 shared papers)Inna Y. Gong (2 shared papers)Rushad D Patell (2 shared papers)
- Journals
- British Journal of Haematology (8 papers)Blood (3 papers)Cochrane Database of Systematic Reviews (2 papers)The Lancet Oncology (2 papers)Blood Advances (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Stephen W. Booth
35 papers receiving 1.8k citations
Stephen W. Booth's Hit Papers
Peers
Comparison fields: 5 of 90
- Infectious Diseases 661
- Oncology 844
- Hematology 138
- Genetics 128
- Neurology 149
Countries citing papers authored by Stephen W. Booth
This map shows the geographic impact of Stephen W. Booth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen W. Booth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen W. Booth more than expected).
Fields of papers citing papers by Stephen W. Booth
This network shows the impact of papers produced by Stephen W. Booth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen W. Booth. The network helps show where Stephen W. Booth may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen W. Booth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients Hit paper breakdown → | 2020 | 474 |
| 2 | COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study Hit paper breakdown → | 2020 | 443 |
| 3 | COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) Hit paper breakdown → | 2021 | 239 |
| 4 | 2017 | 129 | |
| 5 | 2008 | 70 | |
| 6 | 2019 | 50 | |
| 7 | 2022 | 44 | |
| 8 | 2009 | 43 | |
| 9 | 2019 | 37 | |
| 10 | 2022 | 30 | |
| 11 | 2010 | 29 | |
| 12 | 2021 | 25 | |
| 13 | 2020 | 22 | |
| 14 | 2021 | 22 | |
| 15 | 2024 | 20 | |
| 16 | 2022 | 16 | |
| 17 | 2008 | 13 | |
| 18 | 2020 | 13 | |
| 19 | 2019 | 11 | |
| 20 | 2021 | 11 |
About Stephen W. Booth
Stephen W. Booth is a scholar working on Oncology, Pathology and Forensic Medicine, Neurology, Cancer Research and Emergency Medicine, having authored 36 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (11 papers), COVID-19 and healthcare impacts (9 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Genomics and Diagnostics (3 papers), Viral-associated cancers and disorders (3 papers), COVID-19 Clinical Research Studies (2 papers) and Cardiac electrophysiology and arrhythmias (2 papers). The work is most often cited by research in Infectious Diseases (661 citations), Oncology (844 citations), Hematology (138 citations), Genetics (128 citations) and Neurology (149 citations). Stephen W. Booth has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Bruno Fattizzo, John Charles Riches, Lydia Scarfò, Thomas Chatzikonstantinou, Lisa K. Hicks, Abi Vijenthira, Inna Y. Gong, Rushad D Patell, Raphaël Lattenist and Jeffrey I. Zwicker. Their work appears in journals such as British Journal of Haematology, Blood, Cochrane Database of Systematic Reviews, The Lancet Oncology and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.